F-box proteins in cancer stemness: An emerging prognostic and therapeutic target

F-box proteins in cancer stemness: An emerging prognostic and therapeutic target

<p dir="ltr">Cancer is a complex heterogenic disease with significant therapeutic challenges. The presence of cancer stem cells (CSCs) in cancer tissue orchestrates tumor growth, progression, and metastasis, the tumor heterogeneity, disease relapse, and therapeutic resistance. Hence,...

Full description

Saved in:

Bibliographic Details
Main Author:	Abdul Q. Khan (14153247) (author)
Other Authors:	Maha Al-Tamimi (17280550) (author), Shahab Uddin (154400) (author), Martin Steinhoff (5340194) (author)
Published:	2021
Subjects:	Biological sciences Biochemistry and cell biology Biomedical and clinical sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences F-box proteins and signaling Cancer pathogenesis Cancer stem cells Stemness Poor clinical outcomes
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Systems-level Characterization of the Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells*[S]
by: Anja M. Billing (1297773)
Published: (2019)

Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes
by: Martin Steinhoff (5340194)
Published: (2022)

Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer
by: Jingxuan Shan (14152608)
Published: (2019)

Expansion of human amniotic epithelial cells using condition cell reprogramming technology
by: Aisha Naeem (14157078)
Published: (2022)

Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
by: Queenie, Fernandes
Published: (2023)

The dual role of autophagy in breast cancer stemness and treatment resistance
by: Anu Jayanthi Panicker (22330129)
Published: (2025)

The multiomics analyses of cancer stem cells isolated from solid tumors can provide insight for their immunological characterization.
by: Neha Gopinath (15431052)
Published: (2023)

PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
by: Pramod Darvin (153341)
Published: (2019)

The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
by: Maysaloun Merhi (4246147)
Published: (2023)

Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes
by: Bushra Memon (4792767)
Published: (2022)

Editorial: Transdetermination, transdifferentiation, and reprogramming of cells: In vitro and in vivo strategies
by: Artur Cieslar-Pobuda (18222593)
Published: (2023)

Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
by: Nihal AlMuraikhi (6002234)
Published: (2019)

Whole Organism Model to Study Molecular Mechanisms of Differentiation and Dedifferentiation
by: Anwar, Areeba
Published: (2020)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
by: Samson Mathews Samuel (11008848)
Published: (2020)

Generation of induced pluripotent stem cell lines from nonaffected parents and monozygotic triplets affected with autism spectrum disorder and epilepsy
by: Gowher Ali (14152593)
Published: (2022)

Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
by: Nassiba Taib (14557385)
Published: (2023)

The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy
by: Shilpa Ravindran (3627299)
Published: (2019)

Amniotic stem cells as a source of regenerative medicine to treat female infertility
by: Aisha Naeem (14157078)
Published: (2022)

Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
by: Lubna Therachiyil (4246156)
Published: (2022)

PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
by: Kirti S. Prabhu (4246144)
Published: (2025)

Generation of a human induced pluripotent stem cell line (QBRIi009-A) from a patient with a heterozygous deletion of FOXA2
by: Ahmed K. Elsayed (13275302)
Published: (2020)

Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene
by: Yasmin W. Abu Aqel (17100289)
Published: (2020)

Dysregulated FOXM1 signaling in the regulation of cancer stem cells
by: Gulab Sher (12984698)
Published: (2022)

Directed differentiation of human pluripotent stem cells into epidermal keratinocyte-like cells
by: Gowher Ali (14152593)
Published: (2022)

Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
by: Sabah Akhtar (5809925)
Published: (2022)

Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids
by: Abdul Q. Khan (14153247)
Published: (2021)

Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma
by: Peter Kubatka (11008854)
Published: (2020)

Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions
by: Reem Khaled M.E. Alsayed (17563251)
Published: (2023)

Effective generation of functional pancreatic β-cells from human derived dental stem cells of apical papilla and bone marrow derived stem cells
by: Duaa Abuarqoub (6672434)
Published: (2023)

Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling
by: Radhakrishnan Vishnubalaji (3563306)
Published: (2019)

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
by: Gh Rasool Bhat (13038132)
Published: (2024)

An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene
by: Ahmed K. Elsayed (13275302)
Published: (2021)

Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
by: Queenie Fernandes (14557388)
Published: (2023)

CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors
by: Mashael Al-toub (3563303)
Published: (2022)

Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes
by: Radhakrishnan Vishnubalaji (3563306)
Published: (2023)

Identification of potential transcription factors that enhance human iPSC generation
by: Nuha T. Swaidan (18595219)
Published: (2020)

The Effect of Sodium Butyrate and Sodium Propionate on Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition (EMT)
by: Kharazi, Dania
Published: (2023)

An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy
by: Nimshitha Pavathuparambil Abdul Manaph (17870420)
Published: (2019)

Investigation of implementing STEM projects in a selective school in the United Arab Emirates
by: ABDALLAH, JAFAR BAHJAT ABDALLAH
Published: (2017)

Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28–29 2017, Doha, Qatar)
by: Sara Deola (58113)
Published: (2018)